Article: FDA approves warning label for Pfizer's Bextra drug.

By Anthony Cronin, The Day, New London, Conn. Knight Ridder/Tribune Business News

Dec. 10--The federal Food and Drug Administration approved new labeling Thursday for Pfizer Inc.'s Bextra drug to warn of possible serious skin reactions and heart-related problems for those who've experienced coronary bypass surgery. The federal regulatory agency said a new "black box" warning on the label will state that some patients have reported a serious and potentially fatal skin reaction, which the agency said is most likely to occur in the first two weeks of treatment.

The agency said the label also would add a warning in bold type about possible heart ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!